Ivanka I. Kostadinova
Sofia, 1431, Bulgaria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Spatiotemporal APLNR Expression Dynamics During Oligodendroglial Remodeling of the Corpus Callosum in the Cuprizone Model.
Journal: International journal of molecular sciences
Published: March 14, 2026
Alpha-Lipoic Acid in Diabetic Peripheral Neuropathy: Addressing the Challenges and Complexities Surrounding a 70-Year-Old Compound.
Journal: Current issues in molecular biology
Published: April 25, 2025
A Morphological and Behavioral Study of Demyelination and Remyelination in the Cuprizone Model: Insights into APLNR and NG2+ Cell Dynamics.
Journal: International journal of molecular sciences
Published: October 15, 2024
25 Hydroxyvitamin D and Cytokine Profile in Patients With Relapsing-Remitting Multiple Sclerosis.
Journal: Cureus
Published: June 02, 2024
Anti-inflammatory and in vitro antioxidant activities of Satureja montana dry extract.
Journal: Folia medica
Published: November 15, 2023
Effect of Plant Extracts Combinations on TNF-α, IL-6 and IL-10 Levels in Serum of Rats Exposed to Acute and Chronic Stress.
Journal: Plants (Basel, Switzerland)
Published: July 28, 2023
Phytochemical Profiling, Antioxidant and Cognitive-Enhancing Effect of Helichrysum italicum ssp. italicum (Roth) G. Don (Asteraceae).
Journal: Plants (Basel, Switzerland)
Published: July 05, 2023
Newly Synthesized Creatine Derivatives as Potential Neuroprotective and Antioxidant Agents on In Vitro Models of Parkinson's Disease.
Journal: Life (Basel, Switzerland)
Published: November 25, 2022
Anxiolytic Effect of Satureja montana Dry Extract and its Active Compounds Rosmarinic Acid and Carvacrol in Acute Stress Experimental Model.
Journal: Journal of integrative neuroscience
Published: April 27, 2022
Composition and chronic toxicity of dry methanol-aqueous extract of wild-growing Satureja montana.
Journal: Folia medica
Published: March 13, 2022
Synthesis and Biological Study of 4-Aminopyridine-Peptide Derivatives Designed for the Treatment of Neurodegenerative Disorders.
Journal: Current Alzheimer research
Published: December 07, 2021
Last Updated: 09/26/2026